EGFR and nasopharyngeal carcinoma: Meta-analysis demonstrated that the PFS of nasopharyngeal carcinoma patients was independent of EGFR overexpression and there was no statistically significant difference (HR = 1.86, 95% CI [0.90, 3.82], P = .09, Fig. 5).